Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients

被引:0
|
作者
Fatemi, Yasin [1 ]
Nikfar, Mohsen [1 ]
Oladazimi, Amir [1 ]
Zheng, Jingyi [2 ]
Hoy, Haley [3 ]
Ali, Haneen [1 ,4 ]
机构
[1] Auburn Univ, Dept Ind & Syst Engn, Auburn, AL 36849 USA
[2] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA
[3] Univ Alabama Huntsville, Coll Nursing, Huntsville, AL 35805 USA
[4] Auburn Univ, Hlth Serv Adm Program, Auburn, AL 36849 USA
关键词
liver transplant; NASH; cardiovascular; machine learning; UNOS; ABO BLOOD-GROUP; BODY-MASS INDEX; ABDOMINAL OBESITY; KIDNEY-DISEASE; RISK; EVENTS; ASSOCIATION; FAILURE; LIMITATIONS; CARDIORISK;
D O I
10.3390/healthcare12121165
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cardiovascular disease is the leading cause of mortality among nonalcoholic steatohepatitis (NASH) patients who undergo liver transplants. In the present study, machine learning algorithms were used to identify important risk factors for cardiovascular death and to develop a prediction model. The Standard Transplant Analysis and Research data were gathered from the Organ Procurement and Transplantation Network. After cleaning and preprocessing, the dataset comprised 10,871 patients and 92 features. Recursive feature elimination (RFE) and select from model (SFM) were applied to select relevant features from the dataset and avoid overfitting. Multiple machine learning algorithms, including logistic regression, random forest, decision tree, and XGBoost, were used with RFE and SFM. Additionally, prediction models were developed using a support vector machine, Gaussian na & iuml;ve Bayes, K-nearest neighbors, random forest, and XGBoost algorithms. Finally, SHapley Additive exPlanations (SHAP) were used to increase interpretability. The findings showed that the best feature selection method was RFE with a random forest estimator, and the most critical features were recipient and donor blood type, body mass index, recipient and donor state of residence, serum creatinine, and year of transplantation. Furthermore, among all the outcomes, the XGBoost model had the highest performance, with an accuracy value of 0.6909 and an area under the curve value of 0.86. The findings also revealed a predictive relationship between features and cardiovascular death after liver transplant among NASH patients. These insights may assist clinical decision-makers in devising strategies to prevent cardiovascular complications in post-liver transplant NASH patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Longitudinal Analyses of Comorbidities and Healthcare Costs Among Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease
    Harrison, Stephen A.
    Kachru, Nandita
    Parker, Emily
    Korrer, Stephanie
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 572A - 573A
  • [32] Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
    Stepanova, Maria
    Kabbara, Khaled
    Mohess, Denise
    Verma, Manisha
    Roche-Green, Alva
    AlQahtani, Saleh
    Ong, Janus
    Burra, Patrizia
    Younossi, Zobair M.
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1506 - 1515
  • [33] ALCOHOL-USE AMONG ALCOHOLIC AND NONALCOHOLIC LIVER-TRANSPLANT RECIPIENTS
    LUCEY, MR
    BLOW, FC
    WILSON, D
    MERION, R
    BERESFORD, TP
    HEPATOLOGY, 1990, 12 (04) : 1017 - 1017
  • [34] A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis
    Suarez, Miguel
    Martinez, Raquel
    Torres, Ana Maria
    Torres, Beatriz
    Mateo, Jorge
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (09) : 3801 - 3809
  • [35] A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis
    Miguel Suárez
    Raquel Martínez
    Ana María Torres
    Beatriz Torres
    Jorge Mateo
    Digestive Diseases and Sciences, 2023, 68 : 3801 - 3809
  • [36] Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients With Nonalcoholic Steatohepatitis
    Dutta, Nirjhar
    Marka, Nicholas
    Lake, John
    Lim, Nicholas
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (09) : 2023 - 2026
  • [37] DIAGNOSING NONALCOHOLIC STEATOHEPATITIS (NASH) AMONG PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): FEQUENCY AND PREDICTORS OF NAFLD ACTIVITY SCORE MEASUREMENT
    Katz, J.
    Heinz, S.
    DiBonaventura, M.
    VALUE IN HEALTH, 2017, 20 (05) : A180 - A180
  • [38] De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients
    Gitto, Stefano
    de Maria, Nicola
    di Benedetto, Fabrizio
    Tarantino, Giuseppe
    Serra, Valentina
    Maroni, Lorenzo
    Cescon, Matteo
    Pinna, Antonio D.
    Schepis, Filippo
    Andreone, Pietro
    Villa, Erica
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 766 - 773
  • [39] The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI
    Lee, David Uihwan
    Bahadur, Aneesh
    Ponder, Reid
    Lee, Ki Jung
    Fan, Gregory Hongyuan
    Chou, Harrison
    Lominadze, Zurabi
    HEPATOLOGY INTERNATIONAL, 2023, 17 (06) : 1393 - 1415
  • [40] The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI
    David Uihwan Lee
    Aneesh Bahadur
    Reid Ponder
    Ki Jung Lee
    Gregory Hongyuan Fan
    Harrison Chou
    Zurabi Lominadze
    Hepatology International, 2023, 17 : 1393 - 1415